Medtronic Closes €3.0B Public Offering of Senior Notes

Download IconDownload Print IconPrint

Medtronic Closes €3.0B Public Offering of Senior Notes

Client News

Related Solutions

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.

On June 3, 2024, Medtronic, Inc., a wholly-owned indirect subsidiary of Medtronic plc, the leading global healthcare technology company, announced the closing of its recent public offering of €850 million aggregate principal amount of 3.650% Senior Notes due 2029, €850 million aggregate principal amount of 3.875% Senior Notes due 2036, €600 million aggregate principal amount of 4.150% Senior Notes due 2043 and €700 million aggregate principal amount of 4.150% Senior Notes due 2053. Medtronic expects to use net proceeds from the offering for general corporate purposes, which may include the repayment of outstanding commercial paper and other indebtedness.

The WilmerHale team advising Medtronic was led by Justin Ochs and Craig Hilts, and included Andrew Langworthy, Sarah Matchett and Emily Ivers, with assistance from Julie Hogan Rodgers and Ben Kelsey (Tax), Timothy Silva and Ben Lobley (Investment Management) and Heidi Treiber (Corporate).

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel